HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linda Wietecha Selected Research

Atomoxetine Hydrochloride (Strattera)

1/2017Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial.
1/2017Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms.
11/2013Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
5/2012Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning.
3/2011Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial.
9/2010Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD.
12/2009Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linda Wietecha Research Topics

Disease

7Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 12/2009
4Dyslexia (Alexia)
01/2017 - 12/2009
3Migraine Disorders (Migraine)
10/2022 - 12/2018
2Sluggish Cognitive Tempo
01/2017 - 11/2013
1Constipation
10/2022
1Pain (Aches)
12/2018
1Headache (Headaches)
12/2018
1Wounds and Injuries (Trauma)
09/2010

Drug/Important Bio-Agent (IBA)

7Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2017 - 12/2009
2galcanezumabIBA
10/2022 - 01/2022
1erenumabIBA
10/2022
1Monoclonal AntibodiesIBA
10/2022
1LigandsIBA
10/2022
1Calcitonin Gene-Related PeptideIBA
10/2022
1Pain-FreeIBA
12/2018
1lasmiditanIBA
12/2018
1TeaIBA
12/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2017